Solid Biosciences Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $7.7M |
| FY2017 | $11.3M | $76.2M | $52.1M |
| FY2018 | $14.4M | $139.6M | $86.4M |
| FY2019 | $23.4M | $103.5M | $76.0M |
| FY2020 | $39.1M | $171.2M | $154.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $7.7M |
| FY2017 | $11.3M | $76.2M | $52.1M |
| FY2018 | $14.4M | $139.6M | $86.4M |
| FY2019 | $23.4M | $103.5M | $76.0M |
| FY2020 | $39.1M | $171.2M | $154.7M |